18-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY AS A TOOL FOR RESPONSE PREDICTION IN SOLID TUMOURSDE MAESENEER, D. J; LAMBERT, B; SURMONT, V et al.Acta clinica belgica (Ed. multilingue). 2010, Vol 65, Num 5, pp 291-299, issn 0001-5512, 9 p.Article

Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: Results from 2 phase I studiesSURMONT, V; SMIT, E. F; SENAN, S et al.Lung cancer. 2010, Vol 69, Num 3, pp 302-306, issn 0169-5002, 5 p.Article

Oral UFT, etoposide and leucovorin in recurrent non-small cell lung cancer: A non-randomized phase II studySURMONT, V; AERTS, J. G; VAN KLAVEREN, R. J et al.Lung cancer. 2009, Vol 66, Num 3, pp 333-337, issn 0169-5002, 5 p.Article

The effect of radical treatment and rehabilitation on muscle mass and strength: A randomized trial in stages I―III lung cancer patientsSALHI, B; HUYSSE, W; VAN MAELE, G et al.Lung cancer. 2014, Vol 84, Num 1, pp 56-61, issn 0169-5002, 6 p.Article